Sequence analysis of tau in familial and sporadic progressive supranuclear palsy

Morris, H. R.; Katzenschlager, R.; Janssen, J. C.; Brown, J. M.; Ozansoy, M.; Quinn, N.; Revesz,, T.; Rossor, M. N.; Daniel, S. E.; Wood, N. W.; Lees, A. J.
March 2002
Journal of Neurology, Neurosurgery & Psychiatry;Mar2002, p388
Academic Journal
No abstract available.


Related Articles

  • Progressive supranuclear palsy. Begley, Noreen // Nursing Standard;8/21/2013, Vol. 27 Issue 51, p58 

    A quiz on progressive supranuclear palsy is presented.

  • The Genetics of Frontotemporal Dementia and Related Disorders. Sobrido, M.J.; Wiedau-Pazos, M.; Geschwind, D.H. // Current Genomics;Dec2000, Vol. 1 Issue 4, p339 

    Recent advances in genetics have revolutionized our understanding of dementia. In the most common of the human dementing illnesses-Alzheimer s disease (AD)- mutations in three major genes causing rare dominantly inherited AD (APP, PS1 and PS2), and other contributory genetic risk factors, such...

  • Rational therapeutic approaches to progressive supranuclear palsy. Stamelou, Maria; de Silva, Rohan; Arias-Carrión, Oscar; Boura, Evangelia; Höllerhage, Matthias; Oertel, Wolfgang H.; Müller, Ulrich; Hóglinger, Günter U. // Brain: A Journal of Neurology;Jun2010, Vol. 133 Issue 6, p1578 

    Progressive supranuclear palsy is a sporadic and progressive neurodegenerative disease, most often presenting as a symmetric, akinetic-rigid syndrome with postural instability, vertical supranuclear gaze palsy and frontal lobe deficits. It belongs to the family of tauopathies and involves both...

  • Pointers on palsy. O'Connor, Patrick G.; Berkowitz, Henry D.; Cohn, Peter F.; Gorman, B. David; Lief, Philip D.; Mishell Jr., Daniel R.; Nichols, Gwen L.; Rigsby, Michael O.; Ryan, Michael E. // Cortlandt Forum;12/20/97, Vol. 10 Issue 12, p74 

    Discusses the etiology and cure for progressive supranuclear palsy.

  • Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau. Taniguchi-Watanabe, Sayuri; Arai, Tetsuaki; Kametani, Fuyuki; Nonaka, Takashi; Masuda-Suzukake, Masami; Tarutani, Airi; Murayama, Shigeo; Saito, Yuko; Arima, Kunimasa; Yoshida, Mari; Akiyama, Haruhiko; Robinson, Andrew; Mann, David; Iwatsubo, Takeshi; Hasegawa, Masato // Acta Neuropathologica;Feb2016, Vol. 131 Issue 2, p267 

    Intracellular filamentous tau pathology is the defining feature of tauopathies, which form a subset of neurodegenerative diseases. We have analyzed pathological tau in Alzheimer's disease, and in frontotemporal lobar degeneration associated with tauopathy to include cases with Pick bodies,...

  • Neurodegenerative diseases: TAU goes wild in Drosophila. Brazil, Melanie // Nature Reviews Drug Discovery;Jul2002, Vol. 1 Issue 7, p490 

    Presents an animal model of TAU-related neurodegeneration that may serve to identify therapeutic targets in progressive supranuclear palsy, Alzheimer's disease and frontotemporal dementia. Hyperphosphorylation; Neurofibrillary tangles.

  • A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Ahmed, Zeshan; Cooper, Jane; Murray, Tracey; Garn, Katya; McNaughton, Emily; Clarke, Hannah; Parhizkar, Samira; Ward, Mark; Cavallini, Annalisa; Jackson, Samuel; Bose, Suchira; Clavaguera, Florence; Tolnay, Markus; Lavenir, Isabelle; Goedert, Michel; Hutton, Michael; O'Neill, Michael // Acta Neuropathologica;May2014, Vol. 127 Issue 5, p667 

    Intracellular inclusions composed of hyperphosphorylated filamentous tau are a hallmark of Alzheimer's disease, progressive supranuclear palsy, Pick's disease and other sporadic neurodegenerative tauopathies. Recent in vitro and in vivo studies have shown that tau aggregates do not only seed...

  • Relevance of Mutations in Tau for Understanding the Tauopathies. Goedert, Michel // Current Medicinal Chemistry - Immunology, Endocrine & Metabolic ;Dec2003, Vol. 3 Issue 4, p341 

    Tau protein is the major component of the intracellular filamentous deposits that define a number of neurodegenerative diseases. They include the largely sporadic Alzheimer's disease, progressive supranuclear palsy, corticobasal degeneration, Pick's disease and argyrophilic grain disease, as...

  • A progranulin mutation associated with cortico-basal syndrome in an Italian family expressing different phenotypes of fronto-temporal lobar degeneration. Coppola, Cinzia; Rossi, Giacomina; Barbarulo, Anna; Di Fede, Giuseppe; Foglia, Carolina; Piccoli, Elena; Piscosquito, Giuseppe; Saracino, Dario; Tagliavini, Fabrizio; Cotrufo, Roberto // Neurological Sciences;Feb2012, Vol. 33 Issue 1, p93 

    Cortico-basal syndrome (CBS) is a rare neurodegenerative disease characterised by movement and cognitive disorders. It occurs along the spectrum of fronto-temporal lobar degeneration (FTLD), which also includes fronto-temporal dementia (FTD) and progressive supranuclear palsy (PSP). FTLD has...

  • GENETIC BASIS OF 4R TAUOPATHY IN PROGRESSIVE SUPRANUCLEAR PALSY. Kowalska, A. // Folia Neuropathologica;2005, Vol. 43 Issue 3, p210 

    This article presents an abstract of the research paper "Genetic Basis of 4R Tauopathy in Progressive Supranuclear Palsy," which was discussed in the 13th Conference of the Polish Association of Neuropathologist. Progressive supranuclear palsy (PSP) is a rare form of parkinsonism characterized...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics